Preclinical safety of Baxter's recombinant ADAMTS13

被引：0
|
作者：
Piskernik, C. [1 ]
Dietrich, B. [1 ]
Horling, F. [1 ]
Kubik, S. [1 ]
Ruthsatz, T. [1 ]
Scheiflinger, F. [1 ]
Schwarz, H. P. [1 ]
Muchitsch, E. M. [1 ]
Schiviz, A. [1 ]
机构：
[1] Baxter Innovat GmbH, Vienna, Austria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：789 / 790
页数：2
相关论文
共 50 条
  • [11] Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
    Wendt, Ralph
    Voelker, Linus A.
    Brinkkoetter, Paul T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 382 - 384
  • [12] Pharmacokinetics of a recombinant ADAMTS13 in mice, rats and macaques
    Hoellriegl, W.
    Schiviz, A.
    Hoebarth, G.
    Kubik, S.
    Plaimauer, B.
    Scheiflinger, F.
    Muchitsch, E. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 789 - 789
  • [13] Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
    Asmis, Lars M. M.
    Serra, Andreas
    Krafft, Alexander
    Licht, Abraham
    Leisinger, Elke
    Henschkowski-Serra, Jana
    Ganter, Michael T. T.
    Hauptmann, Steffen
    Tinguely, Marianne
    Hovinga, Johanna A. Kremer A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (25): : 2356 - 2361
  • [14] Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura
    Scully, Marie
    Antun, Ana
    Cataland, Spero R.
    Coppo, Paul
    Dossier, Claire
    Biebuyck, Nathalie
    Hassenpflug, Wolf-Achim
    Kentouche, Karim
    Knoebl, Paul
    Kremer Hovinga, Johanna A.
    Lopez-Fernandez, M. Fernanda
    Matsumoto, Masanori
    Ortel, Thomas L.
    Windyga, Jerzy
    Bhattacharya, Indranil
    Cronin, Michael
    Li, Hong
    Mellgard, Bjorn
    Patel, Munjal
    Patwari, Parth
    Xiao, Shan
    Zhang, Pinghai
    Wang, Linda T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (17): : 1584 - 1596
  • [15] ADAMTS13' s tail tale
    Vanhoorelbeke, Karen
    Feys, Hendrik B.
    De Meyer, Simon F.
    [J]. BLOOD, 2009, 113 (21) : 5039 - 5040
  • [16] ADAMTS13 Alone
    George, James N.
    [J]. BLOOD, 2010, 116 (12) : 2003 - 2004
  • [17] ADAMTS13 and TTP
    Zheng, XL
    Majerus, EM
    Sadler, JE
    [J]. CURRENT OPINION IN HEMATOLOGY, 2002, 9 (05) : 389 - 394
  • [18] Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey
    Rossato, Paolo
    Glantschnig, Helmut
    Leidenmuehler, Peter
    Kopic, Alexandra
    Ruthsatz, Tanja
    Majer, Bernhard
    Schuster, Maria
    Scheiflinger, Friedrich
    Hoellriegl, Werner
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (01) : 56 - 60
  • [19] Recombinant ADAMTS13 in Severe Neonatal Thrombotic Thrombocytopenic Purpura
    Stubbs, Matthew J.
    Kendall, Giles
    Scully, Marie
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (25): : 2391 - 2392
  • [20] ADAMTS13 INHIBITOR ASSESSMENT WITH THE HEMOSIL ACUSTAR ADAMTS13 ACTIVITY ASSAY
    Valsecchi, C.
    Mirabet, M.
    Mancini, I.
    Schiavone, L.
    Mane-Padros, D.
    Peyvandi, F.
    [J]. HAEMATOLOGICA, 2019, 104 : 23 - 24
12345